> top > docs > PMC:3342329 > spans > 19105-20096 > annotations

PMC:3342329 / 19105-20096 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T8922 978-982 Protein denotes CCR5
T8921 881-887 Protein denotes IL-1Ra
T8920 841-845 Protein denotes CCR5
T8919 748-757 Positive_regulation denotes increased
T8918 736-742 Protein denotes IL-1Ra
T8917 531-541 Gene_expression denotes expression
T8916 521-530 Positive_regulation denotes increased
T8915 504-510 Protein denotes C-IAP1
T8914 316-322 Protein denotes IL-1Ra
T8913 283-292 Positive_regulation denotes activated
T8912 217-221 Protein denotes CCR5
T8911 114-118 Protein denotes CCR5
T8910 85-89 Protein denotes CCR5
T8856 978-982 Protein denotes CCR5
T8855 881-887 Protein denotes IL-1Ra
T8854 841-845 Protein denotes CCR5
T8853 736-742 Protein denotes IL-1Ra
T8852 504-510 Protein denotes C-IAP1
T8851 316-322 Protein denotes IL-1Ra
T8850 217-221 Protein denotes CCR5
T8849 114-118 Protein denotes CCR5
T8848 85-89 Protein denotes CCR5
R5896 T8917 T8916 themeOf expression,increased
R5897 T8918 T8919 themeOf IL-1Ra,increased

testone

Id Subject Object Predicate Lexical cue
T8822 748-757 Positive_regulation denotes increased
T8821 575-582 Phosphorylation denotes cleaved
T8820 531-541 Gene_expression denotes expression
T8819 521-530 Positive_regulation denotes increased
T8818 283-292 Positive_regulation denotes activated
T8817 254-264 Negative_regulation denotes inhibition
T8763 978-982 Protein denotes CCR5
T8762 881-887 Protein denotes IL-1Ra
T8761 841-845 Protein denotes CCR5
T8760 736-742 Protein denotes IL-1Ra
T8759 504-510 Protein denotes C-IAP1
T8758 316-322 Protein denotes IL-1Ra
T8757 217-221 Protein denotes CCR5
T8756 114-118 Protein denotes CCR5
T8755 85-89 Protein denotes CCR5
R5872 T8758 T8818 themeOf IL-1Ra,activated
R5873 T8760 T8822 themeOf IL-1Ra,increased
R5887 T8820 T8819 themeOf expression,increased

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T11118 978-982 Protein denotes CCR5
T11117 881-887 Protein denotes IL-1Ra
T11116 841-845 Protein denotes CCR5
T11115 736-742 Protein denotes IL-1Ra
T11114 504-510 Protein denotes C-IAP1
T11113 316-322 Protein denotes IL-1Ra
T11112 217-221 Protein denotes CCR5
T11111 114-118 Protein denotes CCR5
T11110 85-89 Protein denotes CCR5
T11175 868-877 Positive_regulation denotes elevation
T11174 748-757 Positive_regulation denotes increased
T11173 404-414 Gene_expression denotes expression
T11172 303-312 Positive_regulation denotes elevation
R7384 T11113 T11172 themeOf IL-1Ra,elevation
R7385 T11114 T11173 themeOf C-IAP1,expression
R7387 T11115 T11174 themeOf IL-1Ra,increased
R7388 T11117 T11175 themeOf IL-1Ra,elevation

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T10790 978-982 Protein denotes CCR5
T10789 881-887 Protein denotes IL-1Ra
T10788 841-845 Protein denotes CCR5
T10787 736-742 Protein denotes IL-1Ra
T10786 504-510 Protein denotes C-IAP1
T10785 316-322 Protein denotes IL-1Ra
T10784 217-221 Protein denotes CCR5
T10783 114-118 Protein denotes CCR5
T10782 85-89 Protein denotes CCR5
T10850 868-877 Positive_regulation denotes elevation
T10849 748-757 Positive_regulation denotes increased
T10848 521-530 Positive_regulation denotes increased
T10847 394-403 Negative_regulation denotes decreased
T10846 404-414 Gene_expression denotes expression
T10845 303-312 Positive_regulation denotes elevation
T10844 254-264 Negative_regulation denotes inhibition
R7304 T10785 T10845 themeOf IL-1Ra,elevation
R7305 T10786 T10848 themeOf C-IAP1,increased
R7306 T10786 T10846 themeOf C-IAP1,expression
R7328 T10845 T10844 themeOf elevation,inhibition
R7329 T10846 T10847 themeOf expression,decreased
R7307 T10787 T10849 themeOf IL-1Ra,increased
R7308 T10789 T10850 themeOf IL-1Ra,elevation

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T9587 986-990 NN denotes mice
T9586 978-985 NN denotes CCR5−/−
T9585 975-977 IN denotes in
T9584 968-974 NN denotes growth
T9583 959-967 NN denotes melanoma
T9582 956-958 IN denotes of
T9581 945-955 NN denotes inhibition
T9580 941-944 DT denotes the
T9579 938-940 IN denotes in
T9578 926-937 JJ denotes significant
T9577 923-925 VB denotes is
T9576 921-922 -COMMA- denotes ,
T9575 916-921 NN denotes NF-κB
T9574 906-915 VB denotes decreased
T9573 901-905 IN denotes with
T9572 889-900 VB denotes accompanied
T9571 887-888 -COMMA- denotes ,
T9570 881-887 NN denotes IL-1Ra
T9569 878-880 IN denotes of
T9568 868-877 NN denotes elevation
T9567 864-867 DT denotes the
T9566 859-863 IN denotes that
T9565 855-858 CC denotes and
T9564 853-854 -COMMA- denotes ,
T9563 849-853 NN denotes mice
T9562 841-848 NN denotes CCR5−/−
T9561 837-840 DT denotes the
T9560 834-836 IN denotes in
T9559 824-833 VB denotes inhibited
T9558 820-823 VB denotes was
T9557 813-819 NN denotes growth
T9556 804-812 NN denotes melanoma
T9555 799-803 IN denotes that
T9554 791-798 VB denotes suggest
T9553 782-790 NN denotes findings
T9552 776-781 DT denotes These
T9551 773-774 -RRB- denotes )
T9550 772-773 CD denotes 5
T9549 768-771 CC denotes and
T9548 766-767 CD denotes 4
T9547 759-765 NN denotes Figure
T9546 758-759 -LRB- denotes (
T9545 748-757 VB denotes increased
T9544 743-747 VB denotes were
T9543 736-742 NN denotes IL-1Ra
T9542 733-735 IN denotes of
T9541 726-732 NN denotes levels
T9540 722-725 DT denotes the
T9539 718-721 CC denotes and
T9538 716-717 -COMMA- denotes ,
T9537 711-716 NN denotes cells
T9536 704-710 NN denotes killer
T9535 696-703 JJ denotes natural
T9534 690-695 JJ denotes CD57+
T9533 688-689 -COMMA- denotes ,
T9532 683-688 NN denotes cells
T9531 681-682 NN denotes T
T9530 676-680 JJ denotes CD8+
T9529 666-675 JJ denotes cytotoxic
T9528 663-665 IN denotes of
T9527 656-662 NN denotes number
T9526 652-655 DT denotes the
T9525 650-651 -COMMA- denotes ,
T9524 644-650 NN denotes spleen
T9523 640-643 DT denotes the
T9522 636-639 CC denotes and
T9521 630-635 NN denotes tumor
T9520 626-629 DT denotes the
T9519 623-625 IN denotes In
T9518 620-621 -RRB- denotes )
T9517 616-620 NN denotes 3A-D
T9516 609-615 NN denotes Figure
T9515 608-609 -LRB- denotes (
T9514 604-607 NN denotes Bax
T9513 600-603 CC denotes and
T9512 598-599 -COMMA- denotes ,
T9511 597-598 CD denotes 9
T9510 593-596 CC denotes and
T9509 583-592 NN denotes caspase-3
T9508 575-582 VB denotes cleaved
T9507 573-574 -COLON- denotes ;
T9506 568-573 NN denotes genes
T9505 558-567 JJ denotes apoptotic
T9504 551-557 NN denotes target
T9503 545-550 PRP-DOLLAR- denotes their
T9502 542-544 IN denotes of
T9501 531-541 NN denotes expression
T9500 521-530 VB denotes increased
T9499 516-520 IN denotes with
T9498 512-515 CC denotes but
T9497 510-511 -RRB- denotes )
T9496 504-510 NN denotes C-IAP1
T9495 500-503 CC denotes and
T9494 494-499 NN denotes Bcl-2
T9493 493-494 -LRB- denotes (
T9492 487-492 NN denotes genes
T9491 477-486 VB denotes promoting
T9490 471-476 NN denotes tumor
T9489 467-470 CC denotes and
T9488 465-466 -COMMA- denotes ,
T9487 452-465 JJ denotes proliferative
T9486 447-451 NN denotes cell
T9485 445-446 -COMMA- denotes ,
T9484 431-445 JJ denotes anti-apoptotic
T9483 424-430 NN denotes target
T9482 418-423 NN denotes NF-κB
T9481 415-417 IN denotes of
T9480 404-414 NN denotes expression
T9479 394-403 VB denotes decreased
T9478 389-393 IN denotes with
T9477 378-388 VB denotes associated
T9476 373-377 RB denotes also
T9475 369-372 VB denotes was
T9474 360-368 NN denotes activity
T9473 349-359 JJ denotes anti-tumor
T9472 344-348 DT denotes This
T9471 336-342 NN denotes tissue
T9470 330-335 NN denotes tumor
T9469 326-329 DT denotes the
T9468 323-325 IN denotes in
T9467 316-322 NN denotes IL-1Ra
T9466 313-315 IN denotes of
T9465 303-312 NN denotes elevation
T9464 299-302 CC denotes and
T9463 293-298 NN denotes NF-κB
T9462 283-292 VB denotes activated
T9461 268-282 RB denotes constitutively
T9460 265-267 IN denotes of
T9459 254-264 NN denotes inhibition
T9458 250-253 DT denotes the
T9457 245-249 IN denotes with
T9456 234-244 VB denotes associated
T9455 230-233 VB denotes was
T9454 225-229 NN denotes mice
T9453 217-224 NN denotes CCR5−/−
T9452 213-216 DT denotes the
T9451 210-212 IN denotes in
T9450 199-209 NN denotes inhibition
T9449 192-198 NN denotes growth
T9448 186-191 NN denotes tumor
T9447 182-185 DT denotes The
T9446 179-180 -RRB- denotes )
T9445 177-179 NN denotes 1B
T9444 173-176 CC denotes and
T9443 170-172 NN denotes 1A
T9442 163-169 NN denotes Figure
T9441 162-163 -LRB- denotes (
T9440 156-161 NN denotes cells
T9439 147-155 NN denotes melanoma
T9438 143-146 NN denotes B16
T9437 138-142 IN denotes with
T9436 127-137 VB denotes inoculated
T9435 122-126 NN denotes mice
T9434 114-121 JJ denotes CCR5+/+
T9433 110-113 DT denotes the
T9432 107-109 TO denotes to
T9431 98-106 VB denotes compared
T9430 93-97 NN denotes mice
T9429 85-92 NN denotes CCR5−/−
T9428 81-84 DT denotes the
T9427 78-80 IN denotes in
T9426 70-77 JJ denotes smaller
T9425 65-69 RB denotes much
T9424 60-64 VB denotes were
T9423 53-59 NN denotes volume
T9422 49-52 CC denotes and
T9421 42-48 NN denotes weight
T9420 36-41 NN denotes tumor
T9419 31-35 IN denotes that
T9418 25-30 VB denotes found
T9417 22-24 PRP denotes we
T9416 20-21 -COMMA- denotes ,
T9415 15-20 NN denotes study
T9414 7-14 JJ denotes present
T9413 3-6 DT denotes the
T9412 0-2 IN denotes In
R5958 T9415 T9412 arg2Of study,In
R5959 T9415 T9413 arg1Of study,the
R5960 T9415 T9414 arg1Of study,present
R5961 T9417 T9418 arg1Of we,found
R5962 T9418 T9412 arg1Of found,In
R5963 T9418 T9416 arg1Of found,","
R5964 T9421 T9420 arg1Of weight,tumor
R5965 T9421 T9422 arg1Of weight,and
R5966 T9422 T9424 arg1Of and,were
R5967 T9422 T9426 arg1Of and,smaller
R5968 T9423 T9422 arg2Of volume,and
R5969 T9424 T9418 arg2Of were,found
R5970 T9424 T9419 arg1Of were,that
R5971 T9424 T9427 arg1Of were,in
R5972 T9424 T9431 arg1Of were,compared
R5973 T9426 T9424 arg2Of smaller,were
R5974 T9426 T9425 arg1Of smaller,much
R5975 T9430 T9427 arg2Of mice,in
R5976 T9430 T9428 arg1Of mice,the
R5977 T9430 T9429 arg1Of mice,CCR5−/−
R5978 T9432 T9431 arg2Of to,compared
R5979 T9435 T9432 arg2Of mice,to
R5980 T9435 T9433 arg1Of mice,the
R5981 T9435 T9434 arg1Of mice,CCR5+/+
R5982 T9435 T9436 arg2Of mice,inoculated
R5983 T9436 T9437 arg1Of inoculated,with
R5984 T9440 T9437 arg2Of cells,with
R5985 T9440 T9438 arg1Of cells,B16
R5986 T9440 T9439 arg1Of cells,melanoma
R5987 T9440 T9441 arg1Of cells,(
R5988 T9443 T9442 arg1Of 1A,Figure
R5989 T9443 T9444 arg1Of 1A,and
R5990 T9444 T9441 arg2Of and,(
R5991 T9445 T9444 arg2Of 1B,and
R5992 T9446 T9441 arg3Of ),(
R5993 T9450 T9447 arg1Of inhibition,The
R5994 T9450 T9448 arg1Of inhibition,tumor
R5995 T9450 T9449 arg1Of inhibition,growth
R5996 T9450 T9451 arg1Of inhibition,in
R5997 T9450 T9455 arg1Of inhibition,was
R5998 T9450 T9456 arg2Of inhibition,associated
R5999 T9454 T9451 arg2Of mice,in
R6000 T9454 T9452 arg1Of mice,the
R6001 T9454 T9453 arg1Of mice,CCR5−/−
R6002 T9456 T9455 arg2Of associated,was
R6003 T9456 T9457 arg1Of associated,with
R6004 T9459 T9457 arg2Of inhibition,with
R6005 T9459 T9458 arg1Of inhibition,the
R6006 T9459 T9460 arg1Of inhibition,of
R6007 T9463 T9462 arg2Of NF-κB,activated
R6008 T9463 T9464 arg1Of NF-κB,and
R6009 T9464 T9460 arg2Of and,of
R6010 T9464 T9461 arg1Of and,constitutively
R6011 T9464 T9468 arg1Of and,in
R6012 T9465 T9464 arg2Of elevation,and
R6013 T9465 T9466 arg1Of elevation,of
R6014 T9467 T9466 arg2Of IL-1Ra,of
R6015 T9471 T9468 arg2Of tissue,in
R6016 T9471 T9469 arg1Of tissue,the
R6017 T9471 T9470 arg1Of tissue,tumor
R6018 T9474 T9472 arg1Of activity,This
R6019 T9474 T9473 arg1Of activity,anti-tumor
R6020 T9474 T9475 arg1Of activity,was
R6021 T9474 T9477 arg2Of activity,associated
R6022 T9474 T9508 arg1Of activity,cleaved
R6023 T9477 T9475 arg2Of associated,was
R6024 T9477 T9476 arg1Of associated,also
R6025 T9477 T9478 arg1Of associated,with
R6026 T9477 T9499 arg1Of associated,with
R6027 T9477 T9507 arg1Of associated,;
R6028 T9478 T9498 arg1Of with,but
R6029 T9480 T9479 arg2Of expression,decreased
R6030 T9480 T9481 arg1Of expression,of
R6031 T9480 T9489 arg1Of expression,and
R6032 T9483 T9481 arg2Of target,of
R6033 T9483 T9482 arg1Of target,NF-κB
R6034 T9483 T9484 arg1Of target,anti-apoptotic
R6035 T9483 T9487 arg1Of target,proliferative
R6036 T9484 T9485 arg1Of anti-apoptotic,","
R6037 T9487 T9485 arg2Of proliferative,","
R6038 T9487 T9486 arg1Of proliferative,cell
R6039 T9489 T9478 arg2Of and,with
R6040 T9489 T9488 arg1Of and,","
R6041 T9490 T9489 arg2Of tumor,and
R6042 T9490 T9491 arg1Of tumor,promoting
R6043 T9492 T9491 arg2Of genes,promoting
R6044 T9492 T9493 arg1Of genes,(
R6045 T9494 T9495 arg1Of Bcl-2,and
R6046 T9495 T9493 arg2Of and,(
R6047 T9496 T9495 arg2Of C-IAP1,and
R6048 T9497 T9493 arg3Of ),(
R6049 T9499 T9498 arg2Of with,but
R6050 T9501 T9499 arg2Of expression,with
R6051 T9501 T9500 arg2Of expression,increased
R6052 T9501 T9502 arg1Of expression,of
R6053 T9506 T9502 arg2Of genes,of
R6054 T9506 T9503 arg1Of genes,their
R6055 T9506 T9504 arg1Of genes,target
R6056 T9506 T9505 arg1Of genes,apoptotic
R6057 T9508 T9507 arg2Of cleaved,;
R6058 T9509 T9510 arg1Of caspase-3,and
R6059 T9510 T9513 arg1Of and,and
R6060 T9511 T9510 arg2Of 9,and
R6061 T9513 T9508 arg2Of and,cleaved
R6062 T9513 T9512 arg1Of and,","
R6063 T9514 T9513 arg2Of Bax,and
R6064 T9514 T9515 arg1Of Bax,(
R6065 T9517 T9515 arg2Of 3A-D,(
R6066 T9517 T9516 arg1Of 3A-D,Figure
R6067 T9518 T9515 arg3Of ),(
R6068 T9521 T9520 arg1Of tumor,the
R6069 T9521 T9522 arg1Of tumor,and
R6070 T9522 T9519 arg2Of and,In
R6071 T9524 T9522 arg2Of spleen,and
R6072 T9524 T9523 arg1Of spleen,the
R6073 T9527 T9526 arg1Of number,the
R6074 T9527 T9528 arg1Of number,of
R6075 T9527 T9533 arg1Of number,","
R6076 T9532 T9528 arg2Of cells,of
R6077 T9532 T9529 arg1Of cells,cytotoxic
R6078 T9532 T9530 arg1Of cells,CD8+
R6079 T9532 T9531 arg1Of cells,T
R6080 T9533 T9539 arg1Of ",",and
R6081 T9537 T9533 arg2Of cells,","
R6082 T9537 T9534 arg1Of cells,CD57+
R6083 T9537 T9535 arg1Of cells,natural
R6084 T9537 T9536 arg1Of cells,killer
R6085 T9539 T9538 arg1Of and,","
R6086 T9539 T9544 arg1Of and,were
R6087 T9539 T9545 arg2Of and,increased
R6088 T9541 T9539 arg2Of levels,and
R6089 T9541 T9540 arg1Of levels,the
R6090 T9541 T9542 arg1Of levels,of
R6091 T9543 T9542 arg2Of IL-1Ra,of
R6092 T9545 T9519 arg1Of increased,In
R6093 T9545 T9525 arg1Of increased,","
R6094 T9545 T9544 arg2Of increased,were
R6095 T9545 T9546 arg1Of increased,(
R6096 T9547 T9548 arg1Of Figure,4
R6097 T9547 T9549 arg1Of Figure,and
R6098 T9549 T9546 arg2Of and,(
R6099 T9550 T9549 arg2Of 5,and
R6100 T9551 T9546 arg3Of ),(
R6101 T9553 T9552 arg1Of findings,These
R6102 T9553 T9554 arg1Of findings,suggest
R6103 T9557 T9556 arg1Of growth,melanoma
R6104 T9557 T9558 arg1Of growth,was
R6105 T9557 T9559 arg2Of growth,inhibited
R6106 T9559 T9555 arg1Of inhibited,that
R6107 T9559 T9558 arg2Of inhibited,was
R6108 T9559 T9560 arg1Of inhibited,in
R6109 T9559 T9565 arg1Of inhibited,and
R6110 T9563 T9560 arg2Of mice,in
R6111 T9563 T9561 arg1Of mice,the
R6112 T9563 T9562 arg1Of mice,CCR5−/−
R6113 T9565 T9554 arg2Of and,suggest
R6114 T9565 T9564 arg1Of and,","
R6115 T9566 T9565 arg2Of that,and
R6116 T9568 T9567 arg1Of elevation,the
R6117 T9568 T9569 arg1Of elevation,of
R6118 T9568 T9571 arg1Of elevation,","
R6119 T9568 T9572 arg2Of elevation,accompanied
R6120 T9568 T9577 arg1Of elevation,is
R6121 T9568 T9578 arg1Of elevation,significant
R6122 T9570 T9569 arg2Of IL-1Ra,of
R6123 T9572 T9573 arg1Of accompanied,with
R6124 T9575 T9573 arg2Of NF-κB,with
R6125 T9575 T9574 arg2Of NF-κB,decreased
R6126 T9577 T9566 arg2Of is,that
R6127 T9577 T9576 arg1Of is,","
R6128 T9578 T9577 arg2Of significant,is
R6129 T9578 T9579 arg1Of significant,in
R6130 T9581 T9579 arg2Of inhibition,in
R6131 T9581 T9580 arg1Of inhibition,the
R6132 T9581 T9582 arg1Of inhibition,of
R6133 T9584 T9582 arg2Of growth,of
R6134 T9584 T9583 arg1Of growth,melanoma
R6135 T9584 T9585 arg1Of growth,in
R6136 T9587 T9585 arg2Of mice,in
R6137 T9587 T9586 arg1Of mice,CCR5−/−

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T9165 978-982 Protein denotes CCR5
T9164 881-887 Protein denotes IL-1Ra
T9163 841-845 Protein denotes CCR5
T9162 736-742 Protein denotes IL-1Ra
T9161 504-510 Protein denotes C-IAP1
T9160 316-322 Protein denotes IL-1Ra
T9159 217-221 Protein denotes CCR5
T9158 114-118 Protein denotes CCR5
T9157 85-89 Protein denotes CCR5

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T10925 676-679 http://www.uniprot.org/uniprot/P10966 denotes CD8
T10923 676-679 http://www.uniprot.org/uniprot/P01732 denotes CD8
T10920 583-592 http://www.uniprot.org/uniprot/P42574 denotes caspase-3
T10919 504-510 http://www.uniprot.org/uniprot/Q13490 denotes C-IAP1
T10905 881-887 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10904 736-742 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10903 316-322 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10875 978-982 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10874 841-845 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10873 217-221 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10872 114-118 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10871 85-89 http://www.uniprot.org/uniprot/P51681 denotes CCR5

UBERON-AE

Id Subject Object Predicate Lexical cue
T9006 644-650 http://purl.obolibrary.org/obo/UBERON_0002106 denotes spleen
T9002 336-342 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue

GO-BP

Id Subject Object Predicate Lexical cue
T9239 283-298 http://purl.obolibrary.org/obo/GO_0051092 denotes activated NF-κB
T9235 192-209 http://purl.obolibrary.org/obo/GO_0045926 denotes growth inhibition
T9221 968-974 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9220 813-819 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9219 192-198 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

GO-CC

Id Subject Object Predicate Lexical cue
T9291 711-716 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9290 683-688 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9289 156-161 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T9012 344-622 Sentence denotes This anti-tumor activity was also associated with decreased expression of NF-κB target anti-apoptotic, cell proliferative, and tumor promoting genes (Bcl-2 and C-IAP1) but with increased expression of their target apoptotic genes; cleaved caspase-3 and 9, and Bax (Figure 3A-D).
T9011 182-343 Sentence denotes The tumor growth inhibition in the CCR5−/− mice was associated with the inhibition of constitutively activated NF-κB and elevation of IL-1Ra in the tumor tissue.
T9010 0-181 Sentence denotes In the present study, we found that tumor weight and volume were much smaller in the CCR5−/− mice compared to the CCR5+/+ mice inoculated with B16 melanoma cells (Figure 1A and 1B).
T9014 776-991 Sentence denotes These findings suggest that melanoma growth was inhibited in the CCR5−/− mice, and that the elevation of IL-1Ra, accompanied with decreased NF-κB, is significant in the inhibition of melanoma growth in CCR5−/− mice.
T9013 623-775 Sentence denotes In the tumor and the spleen, the number of cytotoxic CD8+ T cells, CD57+ natural killer cells, and the levels of IL-1Ra were increased (Figure 4 and 5).
T152 0-181 Sentence denotes In the present study, we found that tumor weight and volume were much smaller in the CCR5−/− mice compared to the CCR5+/+ mice inoculated with B16 melanoma cells (Figure 1A and 1B).
T153 182-343 Sentence denotes The tumor growth inhibition in the CCR5−/− mice was associated with the inhibition of constitutively activated NF-κB and elevation of IL-1Ra in the tumor tissue.
T154 344-622 Sentence denotes This anti-tumor activity was also associated with decreased expression of NF-κB target anti-apoptotic, cell proliferative, and tumor promoting genes (Bcl-2 and C-IAP1) but with increased expression of their target apoptotic genes; cleaved caspase-3 and 9, and Bax (Figure 3A-D).
T155 623-775 Sentence denotes In the tumor and the spleen, the number of cytotoxic CD8+ T cells, CD57+ natural killer cells, and the levels of IL-1Ra were increased (Figure 4 and 5).
T156 776-991 Sentence denotes These findings suggest that melanoma growth was inhibited in the CCR5−/− mice, and that the elevation of IL-1Ra, accompanied with decreased NF-κB, is significant in the inhibition of melanoma growth in CCR5−/− mice.

simple1

Id Subject Object Predicate Lexical cue
T9358 978-982 Protein denotes CCR5
T9357 881-887 Protein denotes IL-1Ra
T9356 841-845 Protein denotes CCR5
T9355 736-742 Protein denotes IL-1Ra
T9354 504-510 Protein denotes C-IAP1
T9353 316-322 Protein denotes IL-1Ra
T9352 217-221 Protein denotes CCR5
T9351 114-118 Protein denotes CCR5
T9350 85-89 Protein denotes CCR5

DLUT931

Id Subject Object Predicate Lexical cue
T11008 868-877 Negative_regulation denotes elevation
T11007 748-757 Positive_regulation denotes increased
T11006 394-403 Negative_regulation denotes decreased
T11005 521-530 Positive_regulation denotes increased
T11004 404-414 Gene_expression denotes expression
T11003 283-292 Positive_regulation denotes activated
T11002 303-312 Gene_expression denotes elevation
T11001 199-209 Negative_regulation denotes inhibition
T10947 978-982 Protein denotes CCR5
T10946 881-887 Protein denotes IL-1Ra
T10945 841-845 Protein denotes CCR5
T10944 736-742 Protein denotes IL-1Ra
T10943 504-510 Protein denotes C-IAP1
T10942 316-322 Protein denotes IL-1Ra
T10941 217-221 Protein denotes CCR5
T10940 114-118 Protein denotes CCR5
T10939 85-89 Protein denotes CCR5
R7334 T10941 T11001 themeOf CCR5,inhibition
R7335 T10942 T11002 themeOf IL-1Ra,elevation
R7336 T10943 T11004 themeOf C-IAP1,expression
R7337 T10944 T11007 themeOf IL-1Ra,increased
R7338 T10946 T11008 themeOf IL-1Ra,elevation
R7370 T11002 T11003 themeOf elevation,activated
R7372 T11004 T11005 themeOf expression,increased
R7373 T11004 T11006 themeOf expression,decreased

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T11676 268-298 Positive_regulation denotes constitutively activated NF-κB
T11668 107-180 Protein denotes to the CCR5+/+ mice inoculated with B16 melanoma cells (Figure 1A and 1B)
T11652 736-742 Protein denotes IL-1Ra
T11646 906-922 Protein denotes decreased NF-κB,
T11634 415-430 Protein denotes of NF-κB target
T11626 690-716 Entity denotes CD57+ natural killer cells
T11622 268-298 Protein denotes constitutively activated NF-κB
T11620 494-499 Protein denotes Bcl-2
T11616 138-180 Entity denotes with B16 melanoma cells (Figure 1A and 1B)
T11614 313-322 Protein denotes of IL-1Ra
T11605 225-229 Protein denotes mice
T11594 583-592 Protein denotes caspase-3
T11592 487-511 Protein denotes genes (Bcl-2 and C-IAP1)
T11589 558-573 Protein denotes apoptotic genes
T11584 878-887 Protein denotes of IL-1Ra
T11574 837-854 Protein denotes the CCR5−/− mice,
T11573 93-97 Protein denotes mice
T11537 978-990 Protein denotes CCR5−/− mice
T11523 663-717 Entity denotes of cytotoxic CD8+ T cells, CD57+ natural killer cells,
T11522 666-675 Entity denotes cytotoxic
T11505 604-607 Protein denotes Bax
T11503 504-510 Protein denotes C-IAP1
R7562 T11622 T11676 themeOf constitutively activated NF-κB,constitutively activated NF-κB

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T11893 990-991 . denotes .
T11892 986-990 NNS denotes mice
T11891 984-985 NN denotes −
T11890 983-984 NN denotes /
T11889 982-983 CD denotes −
T11888 978-982 CD denotes CCR5
T11887 975-977 IN denotes in
T11886 968-974 NN denotes growth
T11885 959-967 NN denotes melanoma
T11884 956-958 IN denotes of
T11883 945-955 NN denotes inhibition
T11882 941-944 DT denotes the
T11881 938-940 IN denotes in
T11880 926-937 JJ denotes significant
T11879 923-925 VBZ denotes is
T11878 921-922 , denotes ,
T11877 916-921 NNP denotes NF-κB
T11876 906-915 VBN denotes decreased
T11875 901-905 IN denotes with
T11874 889-900 VBN denotes accompanied
T11873 887-888 , denotes ,
T11872 881-887 NN denotes IL-1Ra
T11871 878-880 IN denotes of
T11870 868-877 NN denotes elevation
T11869 864-867 DT denotes the
T11868 859-863 IN denotes that
T11867 855-858 CC denotes and
T11866 853-854 , denotes ,
T11865 849-853 NNS denotes mice
T11864 847-848 CD denotes −
T11863 846-847 VBD denotes /
T11862 845-846 NNP denotes −
T11861 841-845 NNP denotes CCR5
T11860 837-840 DT denotes the
T11859 834-836 IN denotes in
T11858 824-833 VBN denotes inhibited
T11857 820-823 VBD denotes was
T11856 813-819 NN denotes growth
T11855 804-812 NN denotes melanoma
T11854 799-803 IN denotes that
T11853 791-798 VBP denotes suggest
T11852 782-790 NNS denotes findings
T11851 776-781 DT denotes These
T11850 774-775 . denotes .
T11849 773-774 -RRB- denotes )
T11848 772-773 CD denotes 5
T11847 768-771 CC denotes and
T11846 766-767 CD denotes 4
T11845 759-765 NN denotes Figure
T11844 758-759 -LRB- denotes (
T11843 748-757 VBN denotes increased
T11842 743-747 VBD denotes were
T11841 736-742 NN denotes IL-1Ra
T11840 733-735 IN denotes of
T11839 726-732 NNS denotes levels
T11838 722-725 DT denotes the
T11837 718-721 CC denotes and
T11836 716-717 , denotes ,
T11835 711-716 NNS denotes cells
T11834 704-710 NN denotes killer
T11833 696-703 JJ denotes natural
T11832 694-695 NNP denotes +
T11831 690-694 NNP denotes CD57
T11830 688-689 , denotes ,
T11829 683-688 NNS denotes cells
T11828 681-682 NNP denotes T
T11827 679-680 CD denotes +
T11826 676-679 NNP denotes CD8
T11825 666-675 JJ denotes cytotoxic
T11824 663-665 IN denotes of
T11823 656-662 NN denotes number
T11822 652-655 DT denotes the
T11821 650-651 , denotes ,
T11820 644-650 NN denotes spleen
T11819 640-643 DT denotes the
T11818 636-639 CC denotes and
T11817 630-635 NN denotes tumor
T11816 626-629 DT denotes the
T11815 623-625 IN denotes In
T11814 621-622 . denotes .
T11813 620-621 -RRB- denotes )
T11812 616-620 NNP denotes 3A-D
T11811 609-615 NNP denotes Figure
T11810 608-609 -LRB- denotes (
T11809 604-607 NNP denotes Bax
T11808 600-603 CC denotes and
T11807 598-599 , denotes ,
T11806 597-598 CD denotes 9
T11805 593-596 CC denotes and
T11804 583-592 JJ denotes caspase-3
T11803 575-582 VBN denotes cleaved
T11802 573-574 : denotes ;
T11801 568-573 NNS denotes genes
T11800 558-567 JJ denotes apoptotic
T11799 551-557 NN denotes target
T11798 545-550 PRP$ denotes their
T11797 542-544 IN denotes of
T11796 531-541 NN denotes expression
T11795 521-530 VBN denotes increased
T11794 516-520 IN denotes with
T11793 512-515 CC denotes but
T11792 510-511 -RRB- denotes )
T11791 504-510 NN denotes C-IAP1
T11790 500-503 CC denotes and
T11789 494-499 NN denotes Bcl-2
T11788 493-494 -LRB- denotes (
T11787 487-492 NNS denotes genes
T11786 477-486 VBG denotes promoting
T11785 471-476 NN denotes tumor
T11784 467-470 CC denotes and
T11783 465-466 , denotes ,
T11782 452-465 NN denotes proliferative
T11781 447-451 NN denotes cell
T11780 445-446 , denotes ,
T11779 431-445 JJ denotes anti-apoptotic
T11778 424-430 NN denotes target
T11777 418-423 JJ denotes NF-κB
T11776 415-417 IN denotes of
T11775 404-414 NN denotes expression
T11774 394-403 VBN denotes decreased
T11773 389-393 IN denotes with
T11772 378-388 VBN denotes associated
T11771 373-377 RB denotes also
T11770 369-372 VBD denotes was
T11769 360-368 NN denotes activity
T11768 349-359 JJ denotes anti-tumor
T11767 344-348 DT denotes This
T11766 342-343 . denotes .
T11765 336-342 NN denotes tissue
T11764 330-335 NN denotes tumor
T11763 326-329 DT denotes the
T11762 323-325 IN denotes in
T11761 316-322 NN denotes IL-1Ra
T11760 313-315 IN denotes of
T11759 303-312 NN denotes elevation
T11758 299-302 CC denotes and
T11757 293-298 NNP denotes NF-κB
T11756 283-292 VBN denotes activated
T11755 268-282 RB denotes constitutively
T11754 265-267 IN denotes of
T11753 254-264 NN denotes inhibition
T11752 250-253 DT denotes the
T11751 245-249 IN denotes with
T11750 234-244 VBN denotes associated
T11749 230-233 VBD denotes was
T11748 225-229 NNS denotes mice
T11747 223-224 CD denotes −
T11746 222-223 VBD denotes /
T11745 221-222 NNP denotes −
T11744 217-221 NNP denotes CCR5
T11743 213-216 DT denotes the
T11742 210-212 IN denotes in
T11741 199-209 NN denotes inhibition
T11740 192-198 NN denotes growth
T11739 186-191 NN denotes tumor
T11738 182-185 DT denotes The
T11737 180-181 . denotes .
T11736 179-180 -RRB- denotes )
T11735 177-179 CD denotes 1B
T11734 173-176 CC denotes and
T11733 170-172 CD denotes 1A
T11732 163-169 NN denotes Figure
T11731 162-163 -LRB- denotes (
T11730 156-161 NNS denotes cells
T11729 147-155 NN denotes melanoma
T11728 143-146 NNP denotes B16
T11727 138-142 IN denotes with
T11726 127-137 VBN denotes inoculated
T11725 122-126 NNS denotes mice
T11724 120-121 CD denotes +
T11723 119-120 VBD denotes /
T11722 118-119 NNP denotes +
T11721 114-118 NNP denotes CCR5
T11720 110-113 DT denotes the
T11719 107-109 TO denotes to
T11718 98-106 VBN denotes compared
T11717 93-97 NNS denotes mice
T11716 91-92 CD denotes −
T11715 90-91 VBD denotes /
T11714 89-90 NNP denotes −
T11713 85-89 NNP denotes CCR5
T11712 81-84 DT denotes the
T11711 78-80 IN denotes in
T11710 70-77 JJR denotes smaller
T11709 65-69 RB denotes much
T11708 60-64 VBD denotes were
T11707 53-59 NN denotes volume
T11706 49-52 CC denotes and
T11705 42-48 NN denotes weight
T11704 36-41 NN denotes tumor
T11703 31-35 IN denotes that
T11702 25-30 VBD denotes found
T11701 22-24 PRP denotes we
T11700 20-21 , denotes ,
T11699 15-20 NN denotes study
T11698 7-14 JJ denotes present
T11697 3-6 DT denotes the
T11696 0-2 IN denotes In
R7586 T11728 T11730 compound B16,cells
R7587 T11729 T11730 compound melanoma,cells
R7588 T11696 T11702 prep In,found
R7589 T11730 T11727 pobj cells,with
R7590 T11697 T11699 det the,study
R7591 T11698 T11699 amod present,study
R7592 T11699 T11696 pobj study,In
R7593 T11731 T11732 punct (,Figure
R7594 T11700 T11702 punct ",",found
R7595 T11732 T11730 appos Figure,cells
R7596 T11733 T11732 nummod 1A,Figure
R7597 T11701 T11702 nsubj we,found
R7598 T11702 T11702 ROOT found,found
R7599 T11734 T11733 cc and,1A
R7600 T11703 T11708 mark that,were
R7601 T11704 T11705 compound tumor,weight
R7602 T11735 T11733 conj 1B,1A
R7603 T11705 T11708 nsubj weight,were
R7604 T11706 T11705 cc and,weight
R7605 T11707 T11705 conj volume,weight
R7606 T11736 T11732 punct ),Figure
R7607 T11708 T11702 ccomp were,found
R7608 T11709 T11710 advmod much,smaller
R7609 T11737 T11723 punct .,/
R7610 T11710 T11708 acomp smaller,were
R7611 T11711 T11710 prep in,smaller
R7612 T11712 T11714 det the,−
R7613 T11738 T11741 det The,inhibition
R7614 T11713 T11714 compound CCR5,−
R7615 T11714 T11711 pobj −,in
R7616 T11739 T11741 compound tumor,inhibition
R7617 T11715 T11708 conj /,were
R7618 T11716 T11717 nummod −,mice
R7619 T11717 T11715 dobj mice,/
R7620 T11718 T11715 prep compared,/
R7621 T11740 T11741 compound growth,inhibition
R7622 T11719 T11718 prep to,compared
R7623 T11741 T11746 nsubj inhibition,/
R7624 T11720 T11722 det the,+
R7625 T11721 T11722 compound CCR5,+
R7626 T11722 T11723 dep +,/
R7627 T11723 T11702 conj /,found
R7628 T11724 T11725 nummod +,mice
R7629 T11742 T11741 prep in,inhibition
R7630 T11725 T11723 dobj mice,/
R7631 T11726 T11725 acl inoculated,mice
R7632 T11727 T11726 prep with,inoculated
R7633 T11743 T11745 det the,−
R7634 T11744 T11745 compound CCR5,−
R7635 T11745 T11742 pobj −,in
R7636 T11746 T11746 ROOT /,/
R7637 T11747 T11748 nummod −,mice
R7638 T11783 T11782 punct ",",proliferative
R7639 T11784 T11782 cc and,proliferative
R7640 T11748 T11750 nsubjpass mice,associated
R7641 T11785 T11786 npadvmod tumor,promoting
R7642 T11786 T11776 pcomp promoting,of
R7643 T11749 T11750 auxpass was,associated
R7644 T11787 T11786 dobj genes,promoting
R7645 T11788 T11787 punct (,genes
R7646 T11750 T11746 conj associated,/
R7647 T11789 T11787 appos Bcl-2,genes
R7648 T11790 T11789 cc and,Bcl-2
R7649 T11751 T11750 prep with,associated
R7650 T11791 T11789 conj C-IAP1,Bcl-2
R7651 T11792 T11791 punct ),C-IAP1
R7652 T11793 T11773 cc but,with
R7653 T11752 T11753 det the,inhibition
R7654 T11794 T11773 conj with,with
R7655 T11795 T11796 amod increased,expression
R7656 T11796 T11794 pobj expression,with
R7657 T11797 T11796 prep of,expression
R7658 T11753 T11751 pobj inhibition,with
R7659 T11798 T11801 poss their,genes
R7660 T11799 T11801 compound target,genes
R7661 T11800 T11801 compound apoptotic,genes
R7662 T11801 T11797 pobj genes,of
R7663 T11754 T11753 prep of,inhibition
R7664 T11802 T11804 punct ;,caspase-3
R7665 T11803 T11804 compound cleaved,caspase-3
R7666 T11804 T11804 ROOT caspase-3,caspase-3
R7667 T11755 T11756 advmod constitutively,activated
R7668 T11805 T11804 cc and,caspase-3
R7669 T11806 T11804 conj 9,caspase-3
R7670 T11807 T11806 punct ",",9
R7671 T11808 T11806 cc and,9
R7672 T11756 T11757 amod activated,NF-κB
R7673 T11809 T11806 conj Bax,9
R7674 T11810 T11812 punct (,3A-D
R7675 T11757 T11754 pobj NF-κB,of
R7676 T11811 T11812 compound Figure,3A-D
R7677 T11812 T11809 appos 3A-D,Bax
R7678 T11758 T11753 cc and,inhibition
R7679 T11813 T11812 punct ),3A-D
R7680 T11814 T11804 punct .,caspase-3
R7681 T11815 T11843 prep In,increased
R7682 T11816 T11817 det the,tumor
R7683 T11759 T11753 conj elevation,inhibition
R7684 T11817 T11815 pobj tumor,In
R7685 T11818 T11817 cc and,tumor
R7686 T11819 T11820 det the,spleen
R7687 T11820 T11817 conj spleen,tumor
R7688 T11821 T11843 punct ",",increased
R7689 T11822 T11823 det the,number
R7690 T11823 T11843 nsubjpass number,increased
R7691 T11760 T11759 prep of,elevation
R7692 T11761 T11760 pobj IL-1Ra,of
R7693 T11762 T11753 prep in,inhibition
R7694 T11824 T11823 prep of,number
R7695 T11825 T11829 amod cytotoxic,cells
R7696 T11763 T11765 det the,tissue
R7697 T11826 T11829 nmod CD8,cells
R7698 T11827 T11829 nummod +,cells
R7699 T11764 T11765 compound tumor,tissue
R7700 T11828 T11829 compound T,cells
R7701 T11829 T11824 pobj cells,of
R7702 T11830 T11823 punct ",",number
R7703 T11831 T11823 appos CD57,number
R7704 T11765 T11762 pobj tissue,in
R7705 T11832 T11835 nmod +,cells
R7706 T11833 T11835 amod natural,cells
R7707 T11766 T11750 punct .,associated
R7708 T11834 T11835 compound killer,cells
R7709 T11835 T11823 conj cells,number
R7710 T11836 T11835 punct ",",cells
R7711 T11837 T11835 cc and,cells
R7712 T11767 T11769 det This,activity
R7713 T11838 T11839 det the,levels
R7714 T11839 T11835 conj levels,cells
R7715 T11840 T11839 prep of,levels
R7716 T11768 T11769 amod anti-tumor,activity
R7717 T11841 T11840 pobj IL-1Ra,of
R7718 T11842 T11843 auxpass were,increased
R7719 T11843 T11843 ROOT increased,increased
R7720 T11769 T11772 nsubjpass activity,associated
R7721 T11844 T11845 punct (,Figure
R7722 T11845 T11843 npadvmod Figure,increased
R7723 T11770 T11772 auxpass was,associated
R7724 T11846 T11845 nummod 4,Figure
R7725 T11847 T11845 cc and,Figure
R7726 T11848 T11845 nummod 5,Figure
R7727 T11771 T11772 advmod also,associated
R7728 T11849 T11845 punct ),Figure
R7729 T11850 T11843 punct .,increased
R7730 T11772 T11804 ccomp associated,caspase-3
R7731 T11851 T11852 det These,findings
R7732 T11852 T11853 nsubj findings,suggest
R7733 T11853 T11853 ROOT suggest,suggest
R7734 T11854 T11858 mark that,inhibited
R7735 T11855 T11856 compound melanoma,growth
R7736 T11856 T11858 nsubjpass growth,inhibited
R7737 T11773 T11772 prep with,associated
R7738 T11857 T11858 auxpass was,inhibited
R7739 T11774 T11775 amod decreased,expression
R7740 T11858 T11853 ccomp inhibited,suggest
R7741 T11775 T11773 pobj expression,with
R7742 T11859 T11858 prep in,inhibited
R7743 T11860 T11862 det the,−
R7744 T11861 T11862 compound CCR5,−
R7745 T11776 T11775 prep of,expression
R7746 T11862 T11859 pobj −,in
R7747 T11863 T11853 conj /,suggest
R7748 T11864 T11865 nummod −,mice
R7749 T11777 T11778 amod NF-κB,target
R7750 T11865 T11863 dobj mice,/
R7751 T11866 T11863 punct ",",/
R7752 T11867 T11863 cc and,/
R7753 T11778 T11786 dative target,promoting
R7754 T11868 T11879 mark that,is
R7755 T11869 T11870 det the,elevation
R7756 T11779 T11782 amod anti-apoptotic,proliferative
R7757 T11870 T11879 nsubj elevation,is
R7758 T11871 T11870 prep of,elevation
R7759 T11872 T11871 pobj IL-1Ra,of
R7760 T11780 T11782 punct ",",proliferative
R7761 T11873 T11874 punct ",",accompanied
R7762 T11874 T11870 prep accompanied,elevation
R7763 T11875 T11874 prep with,accompanied
R7764 T11876 T11877 amod decreased,NF-κB
R7765 T11781 T11782 compound cell,proliferative
R7766 T11877 T11875 pobj NF-κB,with
R7767 T11878 T11879 punct ",",is
R7768 T11879 T11863 conj is,/
R7769 T11782 T11778 appos proliferative,target
R7770 T11880 T11879 acomp significant,is
R7771 T11881 T11880 prep in,significant
R7772 T11882 T11883 det the,inhibition
R7774 T11883 T11881 pobj inhibition,in
R7775 T11884 T11883 prep of,inhibition
R7776 T11885 T11886 compound melanoma,growth
R7777 T11886 T11884 pobj growth,of
R7779 T11887 T11879 prep in,is
R7780 T11888 T11892 nummod CCR5,mice
R7782 T11889 T11892 nummod −,mice
R7783 T11890 T11892 nmod /,mice
R7784 T11891 T11892 amod −,mice
R7785 T11892 T11887 pobj mice,in
R7786 T11893 T11879 punct .,is

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T11214 868-877 Positive_regulation denotes elevation
T11213 916-921 Protein denotes NF-κB
T11212 881-887 Protein denotes IL-1Ra
T11211 748-757 Positive_regulation denotes increased
T11210 736-742 Protein denotes IL-1Ra
T11209 690-695 Protein denotes CD57+
T11208 676-680 Protein denotes CD8+
T11207 404-414 Gene_expression denotes expression
T11206 404-414 Gene_expression denotes expression
T11205 504-510 Protein denotes C-IAP1
T11204 494-499 Protein denotes Bcl-2
T11203 418-423 Protein denotes NF-κB
T11202 283-292 Positive_regulation denotes activated
T11201 254-264 Negative_regulation denotes inhibition
T11200 303-312 Localization denotes elevation
T11199 283-292 Positive_regulation denotes activated
T11198 316-322 Protein denotes IL-1Ra
T11197 293-298 Protein denotes NF-κB
R7401 T11197 T11199 themeOf NF-κB,activated
R7406 T11198 T11200 themeOf IL-1Ra,elevation
R7408 T11199 T11201 themeOf activated,inhibition
R7409 T11200 T11202 themeOf elevation,activated
R7412 T11204 T11206 themeOf Bcl-2,expression
R7417 T11205 T11207 themeOf C-IAP1,expression
R7419 T11210 T11211 themeOf IL-1Ra,increased
R7420 T11212 T11214 themeOf IL-1Ra,elevation